The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

by Martin Shiloh M, Churchill Eric, McKnight Hayes, Mahaffey Christopher M, Ma Yunpeng, O'Donnell Robert T, Tuscano Joseph M
Published 2011-12-01